I am managing and leading the day-to-day business and innovation aspect of approximately life science projects, ranging from early-stage research, clinical trials, product development and strategic collaborations. I am also responsible for identifying and sourcing new business opportunities and develop commercial strategies for each innovation developed by NHS clinicians and researchers.

• Evaluated and analysed technology landscape for the 500 Fortune listed corporates from different industries such as pharmaceuticals and consumer health. • Created technology portfolios and provided recommendation to deliver solutions for clients

Translational support & research commercialisation• Evaluated research output and contributed to develop and execute 10 commercialisation projects (licensing and spinouts) from academic research across 4 leading technology transfer offices (UCLB, Imperial College London, LifeArc, QMUL) • Performed prior art searches and market due diligence for projects to justify IP position of technologies for patent filing, research/PoC grants• Assessed investment opportunities of academic startups from various sectors including medtech, renewable energy, VR, fintech, etc.• Provided research and writing support for presenting seed investment proposals (funding raised up to £500,000) to investment committee• Reviewed and executed research/commercial/license agreements, and assisted legal teams in negotiation agreements with other parties• Identified 10 potential pharma companies for strategic partnership and provided a recommendation for UK Dementia Research Institute • Organized and managed an investors/stakeholders engagement online event with 300 participants globally

Co-investigator on a therapeutics translational research funded by MRC Confidence in Concept Scheme• Co-Ied and worked with multidisciplinary team on £150,000 funded translational research projects on developing effective treatment for targeted therapy and a rare disease• Wrote grant proposals (up to $600,000) for follow-on large-scale preclinical research and commercialisation

- Developed new technology platform to accelerate ophthalmic drug development and designed novel ocular delivery systems. - Performed management support for business development and raising seed investment

• Proposed and developed a conceptual study of using textile technology called electrospinning/electrospray to produce novel biopharmaceuticals formulations• Applied the design of experiment (DOE) statistic approach to predict and control the reproducibility in pharmaceutical manufacturing process• Explored and developed the application of electrohydrodynamic technique to produce vaccine micropatch

Dispensed medicines and advised patients to deliver care for acute and chronic diseases.